Deep Mutational Scan of a cardiac sodium channel voltage sensor

Glazer, A. M., Kroncke, B. M., Matreyek, K. A., Yang, T., Wada, Y., Shields, T., ... & Roden, D. M.

bioRxiv (2019): 773887.

Variants in ion channel genes have classically been studied in lowthroughput by patch clamping. Deep Mutational Scanning (DMS) is a complementary approach that can simultaneously assess function of thousands of variants. We have developed and validated a method to perform a DMS of variants in SCN5A, which encodes the major voltage-gated sodium channel in the heart. We created a library of nearly all possible variants in a 36 base region of SCN5A in the S4 voltage sensor of domain IV and stably integrated the library into HEK293T cells. In preliminary experiments, challenge with three drugs (veratridine, brevetoxin, and ouabain) could discriminate wildtype channels from gain and loss of function pathogenic variants. High-throughput sequencing of the pre- and post-drug challenge pools was used to count the prevalence of each variant and identify variants with abnormal function. The DMS scores identified 40 putative gain of function and 33 putative loss of function variants. For 8/9 variants, patch clamping data was consistent with the scores. These experiments demonstrate the accuracy of a high-throughput in vitro scan of SCN5A variant function, which can be used to identify deleterious variants in SCN5A and other ion channel genes.

Deep Mutational Scan of a cardiac sodium channel voltage sensor

Products Used in this Publication

Catalog NumberCASProduct NamePrice
98112-41-598112-41-5Brevetoxin PbTx 1Inquiry

Related Products

Catalog NumberCASProduct NamePrice
79580-28-279580-28-2Brevetoxin BInquiry
82983-92-482983-92-4BREVETOXIN CInquiry
85079-48-785079-48-7Brevetoxin PbTx-3Inquiry
155751-73-8155751-73-8BREVETOXIN 9Inquiry
142353-09-1Brevetoxin PbTx-9Inquiry